Ambulatory management of isolated acute deep venous thrombosis (DVT) is the recommended standard of care in selected populations. However, in practice a significant number of patients continue to be managed as in-patients. In this study we aimed to evaluate acute DVT treatment pathways in our emergency department (ED) in practice and to identify barriers to outpatient management.
Featured article: Implementation of an acute DVT ambulatory care pathway in a large urban centre: current challenges and future opportunities
World Thrombosis Day (WTD): impacts of hospitalization, cancer-bearing, and earthquakes
October 13th is World Thrombosis Day, a global movement that aims to focus attention on thrombosis, an often overlooked and misunderstood condition. To mark the occasion we invited Tetsumei Urano, Associate Editor of Thrombosis Journal to tells us about the conditions that the day focuses on.
Articles
-
-
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients
-
Low molecular weight heparins use in pregnancy: a practice survey from Greece and a review of the literature
-
Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
-
Down-regulation of platelet adhesion receptors is a controlling mechanism of thrombosis, while also affecting post-transfusion efficacy of stored platelets
-
Laboratory assessment of rivaroxaban: a review
-
Practical management of patients on apixaban: a consensus guide
-
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
-
The role of prothrombin complex concentrates in reversal of target specific anticoagulants
-
Heparin-induced thrombocytopenia: an update
Recommended reading
The diagnosis and treatment of venous thromboembolism in Asian patients
Kang-Ling Wang et al
Cancer-associated thrombosis in Asia
Pantep Angchaisuksiri
Reduced cardiac function and risk of venous thromboembolism in Asian countries
Ruiqi Zhu, Yu Hu and Liang Tang
Trending articles
Click here to view the most shared articles in the last month!
Aims and scope
Thrombosis Journal is an open-access journal that publishes original articles on aspects of clinical and basic research, new methodology, case reports and reviews in the areas of thrombosis.
Topics of particular interest include the diagnosis of arterial and venous thrombosis, new antithrombotic treatments, new developments in the understanding, diagnosis and treatments of atherosclerotic vessel disease, relations between haemostasis and vascular disease, hypertension, diabetes, immunology and obesity.
Latest article series and supplements
The 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis was held from 6-9 October 2016 in Taipei, Taiwan.
As the official journal of the APSTH, Thrombosis Journal has published a supplement of state of the art review and research articles in conjunction with the congress.
Inflammation and its role in thrombosis
In recent years it has become increasingly clear that the immune system and coagulation pathways interact and influence one another. Inflammation-induced thrombosis is considered a feature of several autoimmune diseases and thus such findings have important consequences for the treatment and management of such diseases.
Asian-Pacific Society on Thrombosis and Hemostasis
The Asian-Pacific Society of Thrombosis and Hemostasis (APSTH) is a non-profit organization that welcomes any medical or scientific professionals with an interest in the field of thrombosis and hemostasis, particularly those professionals from the Asia Pacific Region.
The main objectives of APSTH are to foster and advance clinical and scientific knowledge in the field of thrombosis, hemostasis and vascular biology through promotion of scientific exchange via meetings, publications, and promotion of international cooperation in clinical studies, and standardization of nomenclature and practices in the Asia-Pacific region.
Editors' quotes
"Open access is a critical element in dissemination of knowledge and research data throughout the world. In the field of thrombosis and haemostasis many developments are relevant, not only for the developed world, but also for those in underdeveloped nations where access to journals may be limited. The strength of Thrombosis Journal is that is can be accessed by everyone, everywhere. I strongly encourage scientists to submit their valuable data (clinical and basic research) to Thrombosis Journal, where we provide a platform for the full range of thrombosis and haemostasis related topics (also including case reports and special issue contributions)."
Hugo ten Cate, Editor-in-Chief, Thrombosis Journal
"Treatment and prophylaxis of thrombotic and bleeding disorders is of great importance to the worldwide population, and there is a great need to facilitate the research activities related to this field. The aim of Thrombosis Journal is to provide a platform on which these important studies are visible to all members of the scientific community and public."
Yukio Ozaki, Editor-in-Chief, Thrombosis Journal
Advertisement
Official journal of
-
Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.
Members of APSTH are entitled to a 15% discount on the article processing charge.
Follow
Annual Journal Metrics
-
Speed
51 days to first decision for reviewed manuscripts only
48 days to first decision for all manuscripts
102 days from submission to acceptance
45 days from acceptance to publication
Citation Impact
1.235 - Source Normalized Impact per Paper (SNIP)
10.895 - SCImago Journal Rank (SJR)
3.100 - CiteScore
Usage
270,557 Downloads
242 Altmetric mentions
Advertisement
